Indian Government Extends Deadline for Registration and Monthly Declaration of Tobacco Products

Regulations by 2FIRSTS.ai
Apr.12.2024
Indian Government Extends Deadline for Registration and Monthly Declaration of Tobacco Products
Indian government extends deadline for special registration and monthly declaration process for manufacturers of betel, chewable tobacco, and tobacco products.

According to a report by The Hindu Business Line on April 11, the Indian government has extended the deadline for the implementation of special registration and monthly reporting procedures for manufacturers of betel nut, chewing tobacco, and tobacco products until May 15th.

 

In January, the Central Board of Indirect Taxes and Customs (CBIC) announced new registration and monthly reporting procedures set to be implemented starting on April 1, 2024. The regulations require manufacturers of betel nuts, chewing tobacco, and tobacco products who fail to register their packaging processes with the Goods and Services Tax (GST) authorities by April 1 to pay fines of up to 100,000 rupees (1199 USD), with the penalty terms yet to be announced. However, a recent CBIC notification extended the implementation date of this special program by 45 days, until May 15th.

 

The new regulations require tobacco product manufacturers to electronically fill out Form GST SRM-I within 30 days of the effective date of May 15, 2024, providing detailed information on the packaging machines used for filling and packaging. The special declaration form (GST SRM-II) must also be submitted by the 10th of next month.

 

The Government of Malaysia (GoM) stated that tax evasion on tobacco products is a common practice internationally, and this regulation plays a role in enhancing compliance by strengthening enforcement and administrative mechanisms to curb tax evasion.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

ARAC to 2Firsts | FDA’s Nicotine Pouch Pilot: What Hasn’t Changed Matters Most
ARAC to 2Firsts | FDA’s Nicotine Pouch Pilot: What Hasn’t Changed Matters Most
In a contribution to 2Firsts, U.S. regulatory consultancy ARAC analyzes the FDA’s nicotine pouch PMTA pilot, cautioning that core evidentiary standards remain unchanged. The firm warns against overinterpreting the pilot and urges companies to act now rather than wait for uncertain regulatory shifts.
Oct.21
UK plans law to license vape retailers; unlicensed sales could face heavy fines
UK plans law to license vape retailers; unlicensed sales could face heavy fines
The UK plans a national licensing regime for vape and tobacco sales, making unlicensed retail illegal, and will consult experts on flavours, nicotine strength, packaging and design.
Oct.09 by 2FIRSTS.ai
Indonesian Police to Crack Down on Etomidate-Laced Vapes
Indonesian Police to Crack Down on Etomidate-Laced Vapes
Indonesia’s National Police Criminal Investigation Department (Bareskrim Polri) will continue to take enforcement action against users and distributors of etomidate-laced vape liquids, even though the substance is not yet classified as a narcotic. Brigadier General Eko Hadi Santoso, Director of Narcotics Crimes, said etomidate is an anaesthetic drug regulated under Health Law No. 17 of 2023, but has not been listed as a narcotic or psychotropic substance.
Oct.23 by 2FIRSTS.ai
Opinion | Samrat Chowdhery: Tobacco Price Elasticity—A Convenient Myth?
Opinion | Samrat Chowdhery: Tobacco Price Elasticity—A Convenient Myth?
This opinion piece, submitted by Samrat Chowdhery to 2Firsts, challenges the logic of tobacco price elasticity. It argues that high taxes often harm vulnerable populations and fuel illicit markets rather than reducing smoking.
Oct.21
Illegal Market Surges After Kazakhstan Bans E-Cigarettes; Telegram Becomes the Main Trading Channel
Illegal Market Surges After Kazakhstan Bans E-Cigarettes; Telegram Becomes the Main Trading Channel
Since Kazakhstan banned e-cigarette sales in June 2024, transactions have gone underground, shifting to Telegram and some e-commerce platforms and making enforcement harder; related research indicates the ban has not significantly reduced demand.
Oct.20 by 2FIRSTS.ai
Russian Duma Committee Moves to Embed Local Vape Prohibitions
Russian Duma Committee Moves to Embed Local Vape Prohibitions
Fedot Tumusov, First Deputy Chair of the Duma Health Committee, called vapes the “most dangerous and least controlled” nicotine product and said restricting them should be a priority. While refining a government bill, the committee proposes granting regions the power to ban vape sales. Committee Chair Sergey Leonov said the illicit e-cig market exceeds 60%, with new licensing aimed at cleaning up the sector.
Oct.30 by 2FIRSTS.ai